The global pain management devices market is growing significantly due escalating technological advancement and massive research and development in pain management, increasing demand for point-of-care testing, and reappearance of pain after surgery. Increasing necessity for long-term rehabilitation pain management intended for geriatric population, unmet requirements for neuropathic pain, and increasing government initiatives to develop chronic pain rehabilitation centers in order to improve quality of life are supporting the growth of the global pain management devices market.
Massive unexplored market in pain management devices industry of developing economies are creating abundant opportunities for the pain management devices market to grow at a considerable rate during the projected years. In addition, the advanced research and development facilities, and innovative product developments by the companies are propelling the growth of the pain management devices industry.
The analgesic infusion pumps are further segmented on the basis of type as intrathecal infusion pumps, and external infusion pumps. The electrical stimulators can be further categorized as transcutaneous electrical nerve stimulator and other electrical stimulators; whereas, the neurostimulation devices can be further categorized as deep brain stimulator, spinal cord stimulator, sacral neurostimulator, and others. On the basis of application, the market can be segmented as neuropathic pain, musculoskeletal pain, cancer pain, facial and migraine pain, trauma prompted pain and others.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/pain-management-devices-market/report-sample
Some of the companies operating in the global pain management devices market are B. Braun Melsungen AG, Codman And Shurtleff, Inc., Stryker Corporation, Baxter International, Inc., DJO Global LLC., Boston Scientific Corporation, Medtronic, Inc., Hospira Inc., Smith Medical, Kimberly-Clark Corporation, and St. Jude Medical, Inc.